Hillsdale Investment Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,400
| Closed | -$112K | – | 627 |
|
|
2024
Q1 | $112K | Buy |
+26,400
| New | +$112K | 0.01% | 420 |
|
|
2023
Q3 | – | Sell |
-23,910
| Closed | -$131K | – | 601 |
|
|
2023
Q2 | $131K | Buy |
+23,910
| New | +$131K | 0.01% | 357 |
|
|
2021
Q4 | – | Sell |
-403,291
| Closed | -$2.82M | – | 581 |
|
|
2021
Q3 | $2.82M | Sell |
403,291
-76,849
| -16% | -$537K | 0.22% | 144 |
|
|
2021
Q2 | $4M | Buy |
480,140
+76,849
| +19% | +$640K | 0.32% | 112 |
|
|
2021
Q1 | $2.2M | Hold |
403,291
| – | – | 0.18% | 151 |
|
|
2020
Q4 | $1.73M | Sell |
403,291
-1,300
| -0.3% | -$5.58K | 0.16% | 151 |
|
|
2020
Q3 | $1.22M | Sell |
404,591
-8,300
| -2% | -$25K | 0.12% | 168 |
|
|
2020
Q2 | $1.28M | Buy |
+412,891
| New | +$1.28M | 0.12% | 176 |
|
|
2018
Q4 | – | Sell |
-3,200
| Closed | -$17K | – | 608 |
|
|
2018
Q3 | $17K | Buy |
+3,200
| New | +$17K | ﹤0.01% | 334 |
|
|
2015
Q2 | – | Sell |
-49,300
| Closed | -$287K | – | 532 |
|
|
2015
Q1 | $287K | Hold |
49,300
| – | – | 0.07% | 304 |
|
|
2014
Q4 | $280K | Buy |
+49,300
| New | +$280K | 0.07% | 264 |
|